Fig. 2
From: Androgen receptor expression and clinical significance in breast cancer
Kaplan-meier plot for androgen receptor and breast cancer prognosis. A overall survival (OS). B recurrence-free survival (RFS). C distant metastasis-free survival (DMFS). D RFS for TNBC. E RFS for luminal A. F RFS for luminal B. G RFS for HER2+. X axis represents survival time, Y axis represents survival rate. If HR < 1, indicating a protective factor, and HR > 1, indicating a risk factor. were compared between high and low expressions using the Log-rank test. If P < 0.05, it showed a statistically significant difference between high and low expressions. OS is defined as the duration from the date of breast cancer diagnosis to the date of death from any cause. RFS is measured from the time of breast cancer diagnosis to the occurrence of the first disease recurrence. DMFS is the interval from the initial breast cancer diagnosis to the onset of distant metastases. Red indicates the group with high expression levels, whereas black denotes the group with low expression levels